We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$763M
AUM Growth
+$39.8M
Cap. Flow
+$772K
Cap. Flow %
0.1%
Top 10 Hldgs %
72.89%
Holding
32
New
5
Increased
8
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$19M
2
CMRX
Chimerix, Inc.
CMRX
+$12.5M
3
ABEO icon
Abeona Therapeutics
ABEO
+$9.64M
4
VANI icon
Vivani Medical
VANI
+$6.27M
5
BIOL
Biolase, Inc.
BIOL
+$5.16M

Top Sells

Rank Stock Value
1
ACOR
Acorda Therapeutics
ACOR
+$29.3M
2
MZOR
Mazor Robotics Ltd.
MZOR
+$12.2M
3
RPRX
Repros Therapeutics Inc.
RPRX
+$10M
4
OPK icon
Opko Health
OPK
+$4.19M
5
DSCI
Derma Sciences, Inc. Common Stock (DE)
DSCI
+$2.72M

Sector Composition

Rank Sector Weight
1 Healthcare 80.64%
2 Consumer Staples 0.43%
3 Financials 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
26
Biogen
BIIB
$29.8B
$2.62M 0.34%
7,723
– –
LTS
27
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$442K 0.06%
111,789
– –
LXRX icon
28
Lexicon Pharmaceuticals
LXRX
$1.05B
$216K 0.03%
+33,868
New +$273K
CLDX icon
29
Celldex Therapeutics
CLDX
$2.99B
– –
-1,667
Closed -$324K
ONCT
30
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
– –
-189
Closed -$196K
DSCI
31
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
– –
-326,844
Closed -$2.72M
RPRX
32
DELISTED
Repros Therapeutics Inc.
RPRX
– –
-1,014,164
Closed -$10M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Oracle Investment Management held 32 positions worth $763M, up 5.5% from $723M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Oracle Investment Management's Q4 2014 filing shows 5 new, 8 increased, 6 reduced and 4 closed positions. Its largest new stake was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,942,892 shares worth $20.4M. The largest sale was Acorda Therapeutics, an estimated $29.3M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 79% a quarter earlier, followed by Consumer Staples and Financials.

  • Oracle Investment Management's largest Q4 2014 buy was RAPTOR PHARMACEUTICAL CORP COM STK (DE): 1,942,892 shares worth $20.4M.
  • Oracle Investment Management added most to Chimerix, Inc. in Q4 2014, an estimated $12.5M increase.
  • Oracle Investment Management's biggest Q4 2014 reduction was Acorda Therapeutics, cutting an estimated $29.3M.
  • Oracle Investment Management fully exited Repros Therapeutics Inc. in Q4 2014, selling an estimated $10M.
  • Oracle Investment Management's ten largest holdings make up 73% of its $763M portfolio in Q4 2014.
  • Oracle Investment Management opened 5 new positions and closed 4 in Q4 2014.
  • Oracle Investment Management's portfolio value rose 5.5% quarter-over-quarter to $763M.

Based on Oracle Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.